Spectranetics acquires Covidien's Stellarex DCB for $30mm
Executive Summary
Spectranetics Corp. (medical devices for use in minimally invasive cardiovascular procedures) paid $30mm to buy Covidien PLC’s Stellarex drug-coated balloon (DCB) platform.
Deal Industry
- Medical Devices
-
Pharmaceuticals
- Drug Delivery
-
Medical Devices
-
Surgical Equipment & Devices
- Minimally or Less Invasive
-
Surgical Equipment & Devices
Deal Status
- Final
Deal Type
-
Alliance
- Marketing (Licensing)
- Product Purchase
Questions?
Please contact Sales at: (212) 520-2765 or email [email protected]
You must sign in to use this functionality
Authentication.SignIn.HeadSignInHeader
Email Deal
All set! This article has been sent to my@email.address.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
DCD.EmailPopout.Notice